JPMorgan maintains Biogen stock rating at Neutral ahead of 2026 guidance
Post Content
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
JPMorgan maintains Overweight rating on Walt Disney stock ahead of earnings
Post Content
Scotiabank assumes coverage of CGI stock with Sector Perform rating
Post Content
JPMorgan reiterates Overweight rating on Protagonist Therapeutics stock
Post Content
JPMorgan reiterates Overweight rating on Vera Therapeutics stock
Post Content
JPMorgan maintains Overweight rating on ServiceNow stock amid mixed partner feedback
Post Content
JPMorgan reports rotation from US to international equity ETFs
Post Content
Baker Hughes stock price target raised to $60 by JPMorgan on power systems growth
Post Content
IonQ stock to acquire SkyWater Technology for $1.8 billion
Post Content
Gresham House Asset Management reduces stake in Property Franchise Group
Post Content